Interpreting the Canine CBC: A Diagnostic Approach

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• The interpretation of a canine complete blood count (CBC) necessitates a systematic approach, integrating analytic quality assessment, pattern recognition across cell lines, and correlation with signalment, physical examination, and concurrent laboratory data, emphasizing relative changes and biologic plausibility over absolute values.
• Anemia classification hinges on the absolute reticulocyte count; a count above 60,000/µL signifies regeneration, while total protein levels help differentiate blood loss (hypoproteinemia) from hemolysis (normal or elevated protein).
• Neutrophilia with a left shift indicates active marrow mobilization due to inflammation or infection, whereas a degenerative left shift (immature neutrophils outnumbering mature) suggests demand exceeding marrow capacity and carries a guarded prognosis.
• Thrombocytopenia requires smear verification to rule out artifactual clumping; severe thrombocytopenia (<30,000/µL) necessitates immediate investigation for immune-mediated destruction, infectious disease (e.g., tick-borne pathogens), or marrow failure.
• The CBC serves as an initial clue for disseminated intravascular coagulation (DIC), with thrombocytopenia and schistocytes on the blood smear being key indicators, but definitive diagnosis requires coagulation panel testing (PT, aPTT, fibrinogen, D-dimer).
• Serial CBC monitoring is crucial for assessing response to therapy and detecting complications, such as the development of Evans syndrome (IMHA with thrombocytopenia) or progression of infection, with reticulocyte counts and platelet counts being key parameters to track.

The complete blood count is the most frequently requested laboratory test in small animal practice, yet its interpretive value depends entirely on the clinician's ability to recognize patterns instead of isolated abnormalities. This article provides a systematic framework for evaluating the canine CBC, with emphasis on differential prioritization and the pathophysiologic reasoning that connects laboratory findings to clinical diagnoses. It is written for practicing veterinarians who seek a structured approach to common and uncommon hematologic presentations.

The framework presented here integrates three interpretive layers: analytic quality assessment, pattern recognition across cell lines, and integration with signalment, physical examination, and concurrent laboratory data. Because reference intervals vary between laboratories and analyzers, the approach emphasizes relative changes and biologic plausibility over absolute values. The American Society for Veterinary Clinical Pathology quality assurance guidelines provide the standard for validating reference intervals and ensuring that the laboratory data you interpret are analytically sound.

Interpretation begins before the first cell is counted. Sample quality, anticoagulant ratio, and time to analysis materially affect results. A clotted sample invalidates platelet and cell counts. Delayed analysis permits artifactual changes including pseudothrombocytopenia from platelet clumping and neutrophil degeneration. The MSD Veterinary Manual provides species-specific reference guidance that complements laboratory-generated intervals, particularly when evaluating breeds with known hematologic idiosyncrasies such as greyhounds and sight hounds.

At a Glance

Physiologic Basis of CBC Interpretation

Hematopoiesis and the Bone Marrow Response

The peripheral blood reflects a dynamic equilibrium between bone marrow production, peripheral consumption or destruction, and sequestration. Erythrocytes circulate approximately 100 to 120 days in dogs. The marrow responds to anemia with increased erythropoietin-driven production, and this response requires 48 to 72 hours to manifest as circulating reticulocytes. A regenerative response therefore cannot be expected on the first day of an acute hemorrhagic or hemolytic event. Serial sampling may be necessary to distinguish early regeneration from true nonregenerative disease.

Neutrophils have a short circulating half-life measured in hours. The marrow maintains a large storage pool that can be mobilized rapidly in response to inflammatory stimuli. A left shift, defined by the presence of immature neutrophils in circulation, indicates that the storage pool has been depleted and demand exceeds supply. The absence of a left shift does not exclude inflammation, but its presence confirms an active marrow response.

Platelets are fragments of megakaryocytes, and their production is regulated by thrombopoietin. The marrow can increase platelet production several-fold in response to demand. Because platelets survive 5 to 7 days in circulation, the marrow response to peripheral destruction takes several days to become apparent. Serial platelet counts are therefore more informative than a single measurement in distinguishing destruction from production failure.

Reference Intervals and Biologic Variation

Reference intervals are population-based estimates, not absolute boundaries between health and disease. The ASVCP guidelines recommend that each laboratory validate its own intervals using healthy animals from the population it serves. Breed-specific variation is well documented in dogs. Greyhounds have higher hematocrits and lower neutrophil counts than other breeds. Sighthounds as a group show relative macrocytosis. These variations can lead to misclassification when generic intervals are applied.

Interpretation of test results must also account for the prevalence of disease in the population being evaluated, as emphasized in the veterinary diagnostic testing literature. A mildly decreased platelet count in a healthy-appearing outpatient has different predictive value than the same value in a febrile, icteric dog. The post-test probability of disease depends on pretest probability, and the CBC must be interpreted within that framework.

The Erythron: Anemia Classification

Regenerative Versus Nonregenerative Anemia

The first decision in evaluating anemia is whether the marrow is responding. The absolute reticulocyte count is the most reliable indicator. In dogs, aggregate reticulocytes are the appropriate cell to count. An absolute reticulocyte count above 60,000 per microliter indicates regeneration, with counts above 200,000 per microliter suggesting robust regeneration. The percentage reticulocyte count is misleading because it is influenced by the degree of anemia, the same percentage represents a much larger absolute response in a severely anemic patient.

Regenerative anemias result from blood loss or hemolysis. The total protein concentration helps distinguish these mechanisms. Blood loss lowers both hematocrit and total protein. Hemolysis typically leaves total protein normal or elevated. A regenerative anemia with normal total protein therefore points toward hemolysis, while regenerative anemia with hypo-proteinemia suggests hemorrhage. The MSD Veterinary Manual provides a structured differential list for hemolytic causes including immune-mediated disease, infectious agents, and erythrocyte enzyme defects.

Nonregenerative Anemia

Nonregenerative anemia indicates either inadequate erythropoietin production, marrow disease, or insufficient time for a response to develop. The reticulocyte count must be interpreted in the context of the duration of the anemia. A dog with acute blood loss may have a low reticulocyte count for the first 48 to 72 hours despite an intact marrow response. Repeat evaluation at 3 to 5 days distinguishes early regeneration from true nonregeneration.

Chronic nonregenerative anemia in dogs is most commonly associated with inflammatory disease, chronic kidney disease, or neoplasia. Anemia of inflammatory disease is typically mild to moderate, normocytic, and normochromic, with hematocrit values rarely below 25 percent. Chronic kidney disease produces anemia through decreased erythropoietin production, and the severity correlates with the degree of renal dysfunction. Primary marrow disorders, including aplastic anemia and myelodysplasia, are less common but must be considered when anemia is severe, progressive, or accompanied by abnormalities in other cell lines.

The Leukon: Pattern Recognition

Neutrophilia and the Left Shift

Neutrophilia with a left shift indicates an inflammatory or infectious process with active marrow mobilization. The magnitude of the response correlates with the severity of the stimulus, but corticosteroid and epinephrine effects can produce mature neutrophilia without a left shift. Glucocorticoid-induced neutrophilia results from decreased margination and increased marrow release, and it is typically accompanied by lymphopenia and eosinopenia. Physiologic neutrophilia from epinephrine release is transient and resolves within 30 minutes.

A degenerative left shift, defined by immature neutrophils outnumbering mature neutrophils, carries a guarded prognosis. It indicates that demand exceeds marrow production capacity. Toxic change in neutrophils, including cytoplasmic basophilia, Dohle bodies, and foamy vacuolation, confirms an inflammatory process and correlates with bacterial infection. The absence of toxic change does not exclude sepsis, but its presence strongly supports an infectious etiology.

Lymphocyte and Monocyte Patterns

Lymphopenia is a common finding in dogs and most often reflects endogenous or exogenous glucocorticoid effect. Stress lymphopenia is transient and resolves when the stimulus resolves. Persistent lymphopenia warrants investigation for chronic disease or iatrogenic corticosteroid administration. Lymphocytosis in adult dogs is less common and should prompt evaluation for lymphoid neoplasia, particularly when accompanied by other cytopenias or when the lymphocytes are morphologically atypical.

Monocytosis accompanies chronic inflammation, tissue necrosis, and immune-mediated disease. It is a nonspecific finding but supports an ongoing antigenic or inflammatory stimulus. Eosinophilia suggests parasitism, hypersensitivity, or hypoadrenocorticism. Basophilia is uncommon in dogs and typically accompanies eosinophilia in parasitic or hypersensitivity conditions.

The Platelet Mass: Thrombocytopenia and Thrombocytosis

Thrombocytopenia is the most clinically consequential platelet abnormality in dogs. The first decision is whether the count is real. Platelet clumping, a common artifact of EDTA-dependent aggregation, can produce spurious thrombocytopenia on automated analyzers. Examine the blood smear and, when clumps are present, request a fresh sample collected into citrate or evaluate the estimated platelet count from the smear. A manual estimate of 8 to 15 platelets per oil immersion field corresponds to a count near 150,000 to 300,000 platelets per microliter, but this varies with the smear thickness and the analyzer in use.

Once true thrombocytopenia is confirmed, the priority is to distinguish consumption from decreased production. Severe thrombocytopenia, below 30,000 platelets per microliter, carries a risk of spontaneous hemorrhage. The physical examination guides the next step. Pets with fever, peripheral lymphadenopathy, or mucosal petechiae are more likely to have immune-mediated destruction or infectious disease. Pets with concurrent pancytopenia or nonregenerative anemia are more likely to have marrow failure.

Immune-mediated thrombocytopenia remains a diagnosis of exclusion in most practices. Tick-borne disease testing is warranted in endemic regions before committing to long-term immunosuppression. The American Society for Veterinary Clinical Pathology quality assurance guidelines emphasize that reference intervals and analyzer performance vary between laboratories, so serial counts are best interpreted against the same instrument and laboratory.

Thrombocytosis is usually reactive. Iron deficiency, chronic inflammation, neoplasia, and recent splenectomy all stimulate platelet production. Essential thrombocythemia is rare in dogs. A reactive thrombocytosis does not require treatment and resolves with the underlying condition.

The Coagulation Interface: When the CBC Suggests DIC

The CBC often provides the first clue to disseminated intravascular coagulation. The combination of thrombocytopenia, schistocytes on the blood smear, and prolonged clotting times supports the diagnosis. The MSD Veterinary Manual describes DIC as a consumptive coagulopathy secondary to an underlying disease process, most commonly neoplasia, sepsis, or pancreatitis in dogs.

The platelet count is the most sensitive CBC parameter for DIC, but it is not specific. A decreasing platelet count over 24 to 48 hours in a hospitalized dog with a known trigger is more concerning than a single low value. Schistocytes, fragmented red cells produced by fibrin strands in the microvasculature, support the diagnosis but are not always present. The absence of schistocytes does not exclude DIC.

When DIC is suspected, the next step is a coagulation panel: prothrombin time, activated partial thromboplastin time, and fibrinogen or D-dimer concentration. The CBC alone cannot confirm DIC, and treatment decisions should not rest on the platelet count alone. The underlying disease must be identified and addressed, because the coagulopathy will not resolve while the trigger persists.

The Blood Smear: A Structured Review

The automated CBC provides numbers, but the blood smear provides morphology. A structured review should be performed on every abnormal CBC, also when the analyzer flags abnormalities. The examination begins at the feathered edge, where cell distribution is most even, and moves to the monolayer for detailed morphology.

Evaluate red cell morphology systematically. Polychromasia indicates regeneration and should correlate with the reticulocyte count. Spherocytes support immune-mediated hemolysis. Schistocytes suggest microangiopathic hemolysis or DIC. Echinocytes are often artifactual but can accompany uremia or some toxicities. Acanthocytes are associated with hemangiosarcoma and other neoplasms, though they are not pathognomonic.

White cell morphology deserves equal attention. Toxic change in neutrophils, characterized by cytoplasmic basophilia, Dohle bodies, and foamy vacuolation, indicates an inflammatory or septic stimulus. The severity of toxic change often correlates with the intensity of the inflammatory response. Left shift with toxic change is a stronger indicator of bacterial infection than left shift alone. Reactive lymphocytes, with increased cytoplasm and nucleoli, suggest antigenic stimulation. Atypical or blastic cells should prompt cytology of the bone marrow or lymphoid tissue.

Platelet morphology is assessed last. Large platelets, or megathrombocytes, indicate accelerated platelet turnover and support a regenerative thrombopoietic response. The presence of platelet clumps should be recorded and communicated to the clinician, because it affects the reliability of the automated count.

Integrating the CBC With Biochemistry and Imaging

The CBC is rarely interpreted in isolation. The principles of diagnostic test interpretation apply directly: the predictive value of any CBC abnormality depends on the pretest probability of disease in the individual patient. A mild neutrophilia in a young, vaccinated dog with a tick exposure history carries different weight than the same finding in a geriatric dog with weight loss.

The biochemistry panel and urinalysis often narrow the differential list generated by the CBC. A regenerative anemia with hyperbilirubinemia and hemoglobinuria supports hemolysis. A nonregenerative anemia with azotemia suggests chronic kidney disease as the cause of decreased erythropoietin production. A neutrophilia with elevated liver enzymes and hyperbilirubinemia raises the possibility of cholangiohepatitis or steroid hepatopathy, which itself can produce a stress leukogram.

Imaging is indicated when the CBC suggests neoplasia or occult infection. Abdominal ultrasound is the highest-yield modality for dogs with unexplained leukocytosis, thrombocytopenia, or anemia. Splenic masses, hepatic nodules, and abdominal lymphadenopathy are common findings that change the diagnostic plan. Thoracic radiographs are indicated when neoplasia is suspected, particularly for hemangiosarcoma, which metastasizes to the lung early.

The decision to pursue bone marrow evaluation depends on the CBC pattern. Indications include persistent unexplained cytopenia, pancytopenia, suspected marrow neoplasia, and nonregenerative anemia that does not respond to treatment. The diagnostic sample collection and interpretation model used in veterinary curricula reinforces that procedural confidence and interpretive skill develop through structured, repeated practice, which is equally true for the clinician interpreting a marrow aspirate.

Documentation and Serial Monitoring

The CBC is a dynamic test. A single abnormal result establishes a baseline, but the trend over time often carries more diagnostic weight. Document the absolute values, also the interpretation. Record the analyzer used and any sample quality issues, because these affect comparability between serial samples.

For anemic dogs, the reticulocyte count should be repeated at 3 to 5 day intervals to assess the marrow response. A dog that remains nonregenerative after 5 days of appropriate treatment requires reassessment of the initial diagnosis. For thrombocytopenic dogs, the platelet count should be monitored every 24 to 48 hours during the initial treatment phase. The response to immunosuppressive therapy in immune-mediated thrombocytopenia typically occurs within 3 to 7 days.

Serial monitoring also detects complications. A dog treated for immune-mediated hemolytic anemia may develop thrombocytopenia, a phenomenon known as Evans syndrome. A dog with a reactive neutrophilia may develop a left shift and toxic change if the underlying infection progresses. The CBC is the most accessible tool for detecting these shifts, and the documentation should reflect the trajectory, also the current values.

Recognized Complications and Early Detection

The CBC can mislead when preanalytical factors distort results. Clotted samples cause pseudothrombocytopenia and artefactual leukopenia. Delayed processing permits neutrophil degeneration and artefactual left shifts. Lipaemia, hemolysis, and icterus interfere with hemoglobin measurement and red cell indices. Automated analyzers flag nucleated red cells, Heinz bodies, and platelet clumps inconsistently. Early detection requires a disciplined sequence: verify sample quality before releasing results, examine the blood smear whenever the analyzer flags abnormalities, and repeat the count when the clinical picture conflicts with laboratory findings.

Pattern recognition fails when the clinician anchors on a single abnormality. A dog with immune-mediated hemolytic anemia may show spherocytes, autoagglutination, and a marked regenerative response, but concurrent inflammation can mask regeneration by suppressing erythropoietin-driven reticulocytosis. Conversely, a nonregenerative anemia with thrombocytopenia and leukopenia suggests bone marrow disease, yet early lymphoma or ehrlichiosis can produce the same triad. The discriminating step is bone marrow evaluation, not repeated CBCs.

Common Errors and Corrective Actions

Less experienced clinicians frequently misinterpret the reticulocyte count. A single absolute reticulocyte count below 60,000 per microlitre does not distinguish early regeneration from true nonregeneration. The correct approach is serial counts over 48 to 72 hours, because the marrow response lags the onset of anemia. Another common error is dismissing a normal platelet count when clumps are present on the smear. The automated count may be falsely low or falsely normal, the smear is the arbiter.

Students often overinterpret the left shift. A mild left shift with toxic neutrophils supports sepsis, but the absence of toxic change does not exclude bacteremia. Conversely, a degenerative left shift with neutropenia demands immediate investigation for endotoxaemia or overwhelming infection. The corrective action is to integrate the leukon with the erythron and platelet mass instead of interpreting each lineage in isolation.

A third error is treating the reference interval as a diagnostic boundary. A dog with a hematocrit falling from 55% to 38% over three days may be anemic despite a value within the reference interval. Serial monitoring detects trends that single measurements miss. The ASVCP quality assurance guidelines emphasize that reference intervals describe population variation, not individual homeostasis.

Limitations of the Evidence and Divergent Expert Opinion

The evidence base for canine CBC interpretation rests largely on retrospective studies and expert consensus. Prospective validation of decision thresholds is limited. For example, the optimal reticulocyte threshold for classifying regeneration remains contested, with some authorities favouring 80,000 per microlitre and others 100,000. Neither threshold has been validated against bone marrow histology in a large prospective cohort.

Interpretation of test results varies across populations and requires an estimate of disease prevalence in the population being studied, as McKenna and Dohoo explain in their review of diagnostic test interpretation. A mild neutrophilia in a young, vaccinated dog carries different weight than the same finding in a geriatric dog with fever and lymphadenopathy. Expert opinion diverges on when to pursue bone marrow aspiration versus core biopsy, and on the utility of serial CBCs in monitoring chronic disease. Some hematologists recommend weekly monitoring during immunosuppressive therapy, others argue that clinical assessment is sufficient. The evidence does not resolve this disagreement.

Troubleshooting Table

Referral, Consultation, and Reporting

Referral to a veterinary clinical pathologist is warranted when the CBC shows unexplained pancytopenia, when regeneration fails to appear despite appropriate therapy, or when the smear reveals atypical cells suspicious for neoplasia. Laboratory consultation is also appropriate before initiating cytotoxic chemotherapy or when serial monitoring is required for a patient on immunosuppressive doses of glucocorticoids. The MSD Veterinary Manual provides species-specific guidance on hematologic disorders and their management, but it does not replace direct consultation with a pathologist who can review the smear and correlate findings with the analyzer data.

Regulatory reporting obligations vary by jurisdiction. In many regions, certain tick-borne pathogens that cause hematologic abnormalities, such as Anaplasma species, are reportable. The WOAH terrestrial animal health standards define international notification requirements, but local regulations may impose additional duties. Veterinarians should confirm the current reporting list for their region before assuming a diagnosis carries no public health or trade implications. When in doubt, contact the relevant animal health authority.

Frequently Asked Questions

How Do I Prioritize CBC Abnormalities When Multiple Cell Lines Are Affected?

Address the most immediately life-threatening abnormality first, typically the platelet count or severe anemia, before pursuing the leukocyte pattern. A pancytopenic picture shifts the differential toward bone marrow disease, including aplastic anemia, myelophthisis, or chemotherapy toxicity, and warrants bone marrow evaluation sooner instead of later. When concurrent inflammation and thrombocytopenia exist, determine whether the thrombocytopenia reflects consumption, destruction, or decreased production. Serial CBCs over 24 to 48 hours help separate transient from progressive changes. The ASVCP quality assurance guidelines emphasize verifying critical values with a fresh sample before initiating aggressive therapy, particularly when the clinical picture does not match the laboratory findings.

What Is the Minimum Blood Smear Review When an Automated CBC Is Available?

Even with a reliable analyzer, review a smear when any cell line falls outside the reference interval, when the instrument flags nucleated red cells or immature granulocytes, or when platelet estimates conflict with the impedance count. A structured review should confirm platelet numbers, scan the feathered edge for platelet clumps, assess leukocyte morphology for toxic change or reactive lymphocytes, and estimate reticulocyte numbers when anemia is present. The MSD Veterinary Manual advises that automated differentials misclassify nucleated red cells and reactive lymphocytes with sufficient frequency that manual confirmation remains standard of care for abnormal samples. If time permits only one action, the platelet estimate carries the highest clinical priority because spurious thrombocytopenia from clumping is common and can trigger unnecessary diagnostics.

How Should I Interpret a CBC When the Patient Has Received Recent Glucocorticoids or Transfusions?

Glucocorticoid administration produces a characteriztic stress leukogram with mature neutrophilia, lymphopenia, and eosinopenia that can persist for 24 hours or longer after a single injection. This pattern complicates interpretation of concurrent inflammation, so document drug administration and timing on the submission form. A recent transfusion invalidates the erythron assessment because the measured hemoglobin and hematocrit reflect donor cells, not the patient's regenerative capacity. Reticulocyte counts remain interpretable if the patient's own marrow is responding, but the reticulocyte percentage will be diluted by transfused cells. Wait 48 to 72 hours after transfusion before assessing the erythron for regeneration, and interpret the leukon with knowledge that stored blood contains few viable leukocytes. The AVMA practice resources note that transfusion reactions can also produce hemolysis and thrombocytopenia that confound serial monitoring.

What Do I Do When In-House CBC Results Conflict With the Clinical Picture?

Repeat the test on a fresh sample before altering therapy. Common sources of discrepancy include platelet clumping, lipemia interfering with hemoglobin measurement, and sample clotting from a difficult venipuncture. If the repeat result remains discordant, submit to a reference laboratory for comparison, as analyzer calibration and method differences explain many apparent contradictions. The ASVCP quality assurance guidelines recommend documenting the discrepancy and the corrective action taken in the medical record. When a low hematocrit conflicts with a clinically stable patient, consider hemodilution from an overzealous jugular draw or splenic contraction masking blood loss. Conversely, a normal CBC in a pale, tachycardic patient should prompt evaluation for acute hemorrhage where the erythron has not yet equilibrated.

How Does CBC Interpretation Differ in Puppies Compared With Adult Dogs?

Age-specific reference intervals matter most in the first 16 weeks of life. Puppies have higher lymphocyte counts and lower neutrophil counts than adults, so a mature neutrophilia in a puppy may be clinically significant even when the adult reference interval labels it normal. Physiologic anemia of the neonate resolves by 8 to 12 weeks as erythropoiesis matures. Reticulocyte counts are higher in healthy puppies, and the regenerative response to anemia is often more robust than in adults. The MSD Veterinary Manual notes that reference intervals for puppies are not interchangeable with adult values, and laboratories that provide age-stratified intervals should be preferred. When interpreting serial CBCs in growing dogs, compare results against age-matched intervals instead of the puppy's own earlier values, since normal hematologic maturation shifts several parameters.

How Should I Document CBC Findings and Communicate Them to the Owner?

Record the numeric values, the analyzer used, and the smear review findings in the medical record on the same day the sample is collected. Note any sample quality issues, such as lipemia or clot formation, because these affect interpretation of subsequent comparisons. When communicating with owners, frame the CBC as one component of a diagnostic plan instead of a standalone answer. Explain that the CBC identifies patterns that narrow the list of possible causes, and that confirmatory testing is often needed. Use the AVMA practice resources guidance on client communication to structure the conversation around what the test found, what it means for the pet, and what the next diagnostic step will be. Avoid giving a prognosis based on a single CBC value, and schedule a recheck interval appropriate to the abnormality identified.

Related Clinical & Scientific Guides

• Peripheral Blood Smear Evaluation: A Step-by-Step Guide
• Reticulocyte Counts in Veterinary Medicine: Clinical Utility and Interpretation
• Cerebrospinal Fluid Analysis in Veterinary Neurology: Collection and Interpretation

References and Further Reading

• A review of bovine anaplasmosis (&lt,i&gt,Anaplasma marginale&lt,/i&gt,) with emphasis on epidemiology and diagnostic testing.. 2025.
• Survival of Clostridium difficile and its toxins in equine feces: implications for diagnostic test selection and interpretation.. 2000.
• Agreement in histologic assessments of the pituitary pars intermedia in aged horses.. 2005.
• Comparative evaluation of the cadaveric, radiographic and computed tomographic anatomy of the heads of green iguana (Iguana iguana), common tegu (Tupinambis merianae) and bearded dragon (Pogona vitticeps).. 2012.
• Using and interpreting diagnostic tests.. 2006.
• A model for improving student confidence and experience in diagnostic sample collection and interpretation.. 2006.
• American Society for Veterinary Clinical Pathology Guidelines. American Society for Veterinary Clinical Pathology.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
• American Veterinary Medical Association Practice Resources. American Veterinary Medical Association.

Related Articles

• Cytology of the Liver and Spleen: Diagnostic Utility and Interpretation
• Feline CBC Interpretation: Species-Specific Considerations
• Serum Biochemistry Interpretation: A Problem-Oriented Approach
• Cytology of Lymph Nodes: Diagnostic Approach to Lymphadenopathy
• Thrombocytopenia in Dogs and Cats: Diagnostic Approach and Differential Prioritization

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.